Commonwealth Bank of Australia (ASX: CBA) and Westpac Banking Corp (ASX: WBC) shares are both up this morning.
Commonwealth Bank and Westpac are Australia’s two largest banks ahead of Australia and New Zealand Banking Group (ASX: ANZ) and National Australia Bank Ltd (ASX: NAB).
Bank APRA lobbying boosts share prices
According to the Australian Financial Review, as reported by leading journalist Jonathan Shapiro, the major banks are trying to convince APRA (the banking regulator) not to force them to raise $75 billion through Tier II bonds.
The big banks are claiming the global demand for Tier II bonds wouldn’t be enough for them to raise 7% of their risk-weighted assets, which would be between $67 billion and $83 billion over four years — or triple the $25 billion sold over the past four years.
Tier II bank debt is part of a requirement which says banks have to hold capital to protect depositors and senior bondholders against losses. This is so that taxpayers don’t have to bail-out the banks in the future.
Are CBA and Westpac buys today?
Both CBA and Westpac are more reliant on Australia’s housing market than the other two big banks, which could be a worry as the property prices in Sydney and Melbourne are falling right now.
Banks are facing a number of headwinds, including hundreds of millions of dollars of remediation costs from the Royal Commission. Our analyst recently questioned if NAB’s 8% dividend is worth the risk.
I think the big banks have little growth prospects at the moment, whereas there are some ASX shares, like the shares revealed in the free report below, that have excellent growth plans.
2 ASX rapid growth shares to consider
From 2,000 to 2 ASX Growth Shares
After searching through a market with over 2,000 shares, our expert investment analyst has narrowed it down to just 2 of his favourite rapid-growth shares in a FREE report to Rask Media readers.
Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 200.
Idea #1 is taking on the world, starting with the huge USA market. In a just a few short years the company has snatched market share away from rivals and is on its way to being the market leader.
Idea #2 uses a 'printer and cartridge' type model to get large and established customers: a) using their healthcare industry-leading product, b) paying for it again and again and again... so it's little wonder this company is tipped to grow at a rapid pace in 2019.
Access the free report by clicking here now. Absolutely no credit card or payment details required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).